These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28159936)

  • 1. Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration.
    Krilis M; Qi M; Madigan MC; Wong JWH; Abdelatti M; Guymer RH; Whitelock J; McCluskey P; Zhang P; Qi J; Hunyor AP; Krilis SA; Giannakopoulos B
    Oncotarget; 2017 Jul; 8(30):49016-49032. PubMed ID: 28159936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration.
    Krilis M; Qi M; Qi J; Wong JWH; Guymer R; Liew G; Hunyor AP; Madigan M; McCluskey P; Weaver J; Krilis SA; Giannakopoulos B
    Free Radic Biol Med; 2018 Dec; 129():237-246. PubMed ID: 30253188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.
    Kelly U; Yu L; Kumar P; Ding JD; Jiang H; Hageman GS; Arshavsky VY; Frank MM; Hauser MA; Rickman CB
    J Immunol; 2010 Nov; 185(9):5486-94. PubMed ID: 20876352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.
    Bhutto IA; Baba T; Merges C; Juriasinghani V; McLeod DS; Lutty GA
    Br J Ophthalmol; 2011 Sep; 95(9):1323-30. PubMed ID: 21633121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology.
    Clark SJ; Bishop PN; Day AJ
    Biochem Soc Trans; 2010 Oct; 38(5):1342-8. PubMed ID: 20863311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid.
    Johnson PT; Betts KE; Radeke MJ; Hageman GS; Anderson DH; Johnson LV
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17456-61. PubMed ID: 17079491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of age-related macular degeneration-like pathology by complement factor H.
    Toomey CB; Kelly U; Saban DR; Bowes Rickman C
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3040-9. PubMed ID: 25991857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration.
    Geerlings MJ; Kremlitzka M; Bakker B; Nilsson SC; Saksens NT; Lechanteur YT; Pauper M; Corominas J; Fauser S; Hoyng CB; Blom AM; de Jong EK; den Hollander AI
    JAMA Ophthalmol; 2017 Jan; 135(1):39-46. PubMed ID: 27918759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of complement factor h and fibulin3 in age-related macular degeneration.
    Wyatt MK; Tsai JY; Mishra S; Campos M; Jaworski C; Fariss RN; Bernstein SL; Wistow G
    PLoS One; 2013; 8(6):e68088. PubMed ID: 23840815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
    Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
    Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
    Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
    JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.
    Silva AS; Teixeira AG; Bavia L; Lin F; Velletri R; Belfort R; Isaac L
    Mol Vis; 2012; 18():2288-99. PubMed ID: 22969267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration.
    Clark SJ; Schmidt CQ; White AM; Hakobyan S; Morgan BP; Bishop PN
    J Immunol; 2014 Nov; 193(10):4962-70. PubMed ID: 25305316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.
    Clark SJ; Perveen R; Hakobyan S; Morgan BP; Sim RB; Bishop PN; Day AJ
    J Biol Chem; 2010 Sep; 285(39):30192-202. PubMed ID: 20660596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
    Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
    Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential participation of CTRP6, a complement regulator, in the pathology of age related macular degeneration.
    Shinomiya K; Mukai A; Ito E; Yoneda K; Ueno M; Sotozono C; Kinoshita S; Hamuro J
    Jpn J Ophthalmol; 2022 May; 66(3):326-334. PubMed ID: 35397057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extramacular drusen are highly associated with age-related macular degeneration, but not with CFH and ARMS2 genotypes.
    Ersoy L; Schick T; de Graft D; Felsch M; Hoyng CB; den Hollander AI; Kirchhof B; Fauser S; Liakopoulos S
    Br J Ophthalmol; 2016 Aug; 100(8):1047-51. PubMed ID: 26614632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype.
    Radu RA; Hu J; Jiang Z; Bok D
    J Biol Chem; 2014 Mar; 289(13):9113-20. PubMed ID: 24550392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.
    Lorés-Motta L; van Beek AE; Willems E; Zandstra J; van Mierlo G; Einhaus A; Mary JL; Stucki C; Bakker B; Hoyng CB; Fauser S; Clark SJ; de Jonge MI; Nogoceke E; Koertvely E; Jongerius I; Kuijpers TW; den Hollander AI
    Am J Hum Genet; 2021 Aug; 108(8):1367-1384. PubMed ID: 34260947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc supplementation inhibits complement activation in age-related macular degeneration.
    Smailhodzic D; van Asten F; Blom AM; Mohlin FC; den Hollander AI; van de Ven JP; van Huet RA; Groenewoud JM; Tian Y; Berendschot TT; Lechanteur YT; Fauser S; de Bruijn C; Daha MR; van der Wilt GJ; Hoyng CB; Klevering BJ
    PLoS One; 2014; 9(11):e112682. PubMed ID: 25393287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.